{"id":"https://openalex.org/W2148686475","doi":"https://doi.org/10.1200/jco.2004.00.1438","title":"Phase I/IIa Study of Cetuximab With Gemcitabine Plus Carboplatin in Patients With Chemotherapy-Na\u00efve Advanced Non\u2013Small-Cell Lung Cancer","display_name":"Phase I/IIa Study of Cetuximab With Gemcitabine Plus Carboplatin in Patients With Chemotherapy-Na\u00efve Advanced Non\u2013Small-Cell Lung Cancer","publication_year":2005,"publication_date":"2005-11-22","ids":{"openalex":"https://openalex.org/W2148686475","doi":"https://doi.org/10.1200/jco.2004.00.1438","mag":"2148686475","pmid":"https://pubmed.ncbi.nlm.nih.gov/16301597"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.00.1438","doi":"https://doi.org/10.1200/jco.2004.00.1438","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.00.1438","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/12","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113784180","display_name":"Francisco Robert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco Robert","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057109001","display_name":"George Blumenschein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Blumenschein","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008593691","display_name":"Roy S. Herbst","orcid":"https://orcid.org/0000-0003-2535-5847","observed_orcids":["https://orcid.org/0000-0003-2535-5847"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy S. Herbst","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009466654","display_name":"Frank V. Fossella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank V. Fossella","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001486324","display_name":"Jennifer E. Tseng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Tseng","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087541775","display_name":"Mansoor Noorali Saleh","orcid":"https://orcid.org/0000-0003-0209-8630","observed_orcids":["https://orcid.org/0000-0003-0209-8630"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mansoor N. Saleh","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014735331","display_name":"Michael N. Needle","orcid":"https://orcid.org/0000-0002-6182-0569","observed_orcids":["https://orcid.org/0000-0002-6182-0569"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Needle","raw_affiliation_strings":["From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; M.D. Anderson Cancer Center, Houston, TX; M.D. Anderson Cancer Center Orlando, FL; Georgia Cancer Specialists, Marietta, GA; and ImClone Systems Inc, Branchburg, NJ","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I32389192","https://openalex.org/I4210156026"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":17.3448,"has_fulltext":false,"cited_by_count":149,"citation_normalized_percentile":{"value":0.99465152,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"23","issue":"36","first_page":"9089","last_page":"9096"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6050000190734863},{"id":"https://openalex.org/keywords/acne-like-rash","display_name":"acne-like rash","score":0.8299999833106995},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8920000195503235},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.6600000262260437},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9121533036231995},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8801743984222412},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8770334720611572},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.836036205291748},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6837033033370972},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.637779951095581},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5963840484619141},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5244241952896118},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5000362396240234},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.34490418434143066},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2004.00.1438","doi":"https://doi.org/10.1200/jco.2004.00.1438","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.00.1438","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:16301597","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16301597","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:ecommons.aku.edu:eastafrica_fhs_mc_haematol_oncol-1011","doi":null,"is_oa":true,"landing_page_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/12","pdf_url":null,"source":{"id":"https://openalex.org/S4377196301","display_name":"eCommons - AKU (Aga Khan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118185606","host_organization_name":"Aga Khan University","host_organization_lineage":["https://openalex.org/I118185606"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematology and Oncology, East Africa","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:ecommons.aku.edu:eastafrica_fhs_mc_haematol_oncol-1011","doi":null,"is_oa":true,"landing_page_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/12","pdf_url":null,"source":{"id":"https://openalex.org/S4377196301","display_name":"eCommons - AKU (Aga Khan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118185606","host_organization_name":"Aga Khan University","host_organization_lineage":["https://openalex.org/I118185606"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematology and Oncology, East Africa","raw_type":"text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W1527076593","https://openalex.org/W1579889152","https://openalex.org/W1645126533","https://openalex.org/W1653571790","https://openalex.org/W1804903119","https://openalex.org/W1814699096","https://openalex.org/W1899541887","https://openalex.org/W1935885922","https://openalex.org/W1939364580","https://openalex.org/W1964414545","https://openalex.org/W1972336456","https://openalex.org/W1981608739","https://openalex.org/W1983104536","https://openalex.org/W2002602526","https://openalex.org/W2009346207","https://openalex.org/W2023389550","https://openalex.org/W2037139573","https://openalex.org/W2037521712","https://openalex.org/W2038882649","https://openalex.org/W2043696829","https://openalex.org/W2047083378","https://openalex.org/W2050105922","https://openalex.org/W2057458801","https://openalex.org/W2058586542","https://openalex.org/W2073464554","https://openalex.org/W2088658971","https://openalex.org/W2096008575","https://openalex.org/W2103376804","https://openalex.org/W2106764013","https://openalex.org/W2108523633","https://openalex.org/W2109960839","https://openalex.org/W2110835998","https://openalex.org/W2119321434","https://openalex.org/W2127101185","https://openalex.org/W2127405377","https://openalex.org/W2135422811","https://openalex.org/W2138604360","https://openalex.org/W2139195277","https://openalex.org/W2139236349","https://openalex.org/W2139248078","https://openalex.org/W2143536404","https://openalex.org/W2150079073","https://openalex.org/W2151220251","https://openalex.org/W2152452482","https://openalex.org/W2155977433","https://openalex.org/W2159506251","https://openalex.org/W2161821474","https://openalex.org/W2162724777","https://openalex.org/W2164332056","https://openalex.org/W2164844879","https://openalex.org/W2166399931","https://openalex.org/W2167531081","https://openalex.org/W2170517479","https://openalex.org/W2171685800","https://openalex.org/W2242848604","https://openalex.org/W2244058194","https://openalex.org/W2297901492","https://openalex.org/W2313284959","https://openalex.org/W2343670117","https://openalex.org/W3041047318","https://openalex.org/W4240577843"],"related_works":["https://openalex.org/W2116385092","https://openalex.org/W2286278842","https://openalex.org/W2604362388","https://openalex.org/W1972473164","https://openalex.org/W2275177970","https://openalex.org/W2287184838","https://openalex.org/W2081714604","https://openalex.org/W2120612535","https://openalex.org/W2046890706","https://openalex.org/W2607358647"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"multicenter,":[2],"open-label,":[3],"phase":[4],"I/IIa":[5],"study":[6,172],"was":[7,81,181,210,218,229],"undertaken":[8],"to":[9,38,49,136,165,188,208,244],"establish":[10],"the":[11,83,96,171,182,214],"safety/toxicity":[12],"profile":[13],"of":[14,42,62,66,76,90,126,160,174,224],"cetuximab":[15,77,137],"in":[16,22],"combination":[17,223],"with":[18,24,68,232],"gemcitabine":[19,103,228],"and":[20,51,71,102,109,147,155,213,227,249,254],"carboplatin":[21],"patients":[23,58,194,201],"chemotherapy-na\u00efve,":[25],"epidermal":[26],"growth":[27],"factor":[28],"receptor-positive,":[29],"stage":[30],"IV":[31],"non-small-cell":[32],"lung":[33],"cancer.":[34],"Secondary":[35],"objectives":[36],"were":[37,111,117,163,242],"gather":[39],"preliminary":[40],"evidence":[41],"efficacy":[43],"including":[44],"tumor":[45,120],"response":[46,121,247],"rate,":[47],"time":[48,207],"progression,":[50],"overall":[52,216],"survival.":[53],"PATIENTS":[54],"AND":[55],"METHODS:":[56],"Thirty-five":[57],"received":[59],"a":[60,175],"total":[61],"264":[63],"3-week":[64],"cycles":[65,125],"treatment":[67],"cetuximab,":[69,225],"carboplatin,":[70,226],"gemcitabine.":[72],"An":[73],"initial":[74],"dose":[75],"400":[78],"mg/m2":[79,105],"intravenously":[80],"administered":[82,112],"first":[84],"week,":[85],"followed":[86],"by":[87],"weekly":[88],"doses":[89],"250":[91],"mg/m2.":[92],"Carboplatin":[93],"(area":[94],"under":[95],"curve":[97],"=":[98],"5,":[99],"day":[100],"1)":[101],"1,000":[104],"on":[106],"days":[107],"1":[108],"8":[110],"every":[113,123],"3":[114,177,239],"weeks.":[115],"Patients":[116],"evaluated":[118],"for":[119],"after":[122],"two":[124],"therapy.":[127],"RESULTS:":[128],"The":[129,158,205,222,246],"most":[130,183],"frequently":[131,184],"reported":[132],"adverse":[133,240],"events":[134,241],"related":[135,187],"included":[138,195],"an":[139,233],"acne-like":[140],"rash":[141],"(88.6%),":[142],"dry":[143],"skin":[144,148],"(34.3%),":[145],"asthenia":[146],"disorders":[149],"(31.4%),":[150],"mucositis/stomatitis":[151],"(25.7%),":[152],"fever/chills":[153],"(20%),":[154],"nausea/vomiting":[156],"(17.1%).":[157],"majority":[159],"these":[161],"toxicities":[162],"mild":[164],"moderate.":[166],"One":[167],"patient":[168],"withdrew":[169],"from":[170],"because":[173],"grade":[176,238],"allergic":[178],"reaction.":[179],"Myelosuppression":[180],"observed":[185],"toxicity":[186,235],"chemotherapy.":[189,245],"Responses":[190],"among":[191],"35":[192],"assessable":[193],"10":[196],"partial":[197],"responses":[198],"(28.6%).":[199],"Twenty-one":[200],"had":[202],"stable":[203],"disease.":[204],"median":[206,215,250],"progression":[209],"165":[211],"days,":[212],"survival":[217,251],"310":[219],"days.":[220],"CONCLUSION:":[221],"well":[230],"tolerated":[231],"acceptable":[234],"profile.":[236],"Most":[237],"attributable":[243],"rate":[248],"are":[252],"encouraging":[253],"warrant":[255],"additional":[256],"investigation.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}